TY - JOUR
T1 - Luteinizing hormone releasing activity of [Gln8]-LHRH and [His5, Trp7, Tyr8]-LHRH in the cockerel, in vivo and in vitro
AU - Chou, Hsu Fang
AU - Johnson, A. L.
AU - Williams, J. B.
N1 - Funding Information:
We wish to thank Dr. R. Weppelman of Merck, Sharp and Dohme, Inc. and Dr. F.J. Cunningham for reagents used in the chicken LH radioimmunoassay, Ms. C. Brown for excellent technical assistance, and Ms. C.J. Uckele for typing the manuscript. This work was funded by NIH Grant HD17432 (to ALJ) and the NJ Agricultural Experiment Station (publication D-06107-01-85).
PY - 1985/12/30
Y1 - 1985/12/30
N2 - The luteinizing hormone (LH)-releasing activity of two distinct chicken luteinizing hormone releasing hormones ([Gln8]-LHRH and [His5, Trp7, Tyr8]-LHRH) were evaluated in white Leghorn cockerels. In the first study, thirty birds were randomly allotted to five groups and injected, i.v., with 0.9% saline, [Gln8]-LHRH (cLHRH I, 1 μM or 10 μM) or [His5, Trp7, Tyr8]-LHRH, (cLHRH II; 1 μM or 10 μM). Blood samples were drawn prior to and through 60 min following the injection, and plasma was collected for LH determination. In the second study, anterior pituitary cells from cockerels were dispersed and preincubated for 1 hr. Approximately 1.5 × 105 cells per tube were incubated with either Medium 199 buffer (control), 8-bromo-cAMP or various doses of cLHRH I or cLHRH II at final concentrations ranging from 0.02 to 100.0 nM. At the end of a two hour incubation, supernatant was collected and the concentration of LH determined. Injection of cLHRH I or cLHRH II at 1 μM and 10 μM levels caused a significant increase in blood LH concentrations which peaked 5 min following injection. There were, however, no differences between the stimulatory effect of cLHRH I compared to cLHRH II at either dose. On the other hand, cLHRH II was found to be 4.7 times more potent than cLHRH I in stimulating LH release from dispersed pituitary cells. It is suggested that cLHRH II may have greater affinity for the gonadotroph receptor, greater uptake by the cell, and/or that it may be more resistant to in vitro degradation than cLHRH I. On the other hand, an extra pituitary site of degradation may be more effective in metabolizing cLHRH II, resulting in its equipotency with cLHRH I, in vivo.
AB - The luteinizing hormone (LH)-releasing activity of two distinct chicken luteinizing hormone releasing hormones ([Gln8]-LHRH and [His5, Trp7, Tyr8]-LHRH) were evaluated in white Leghorn cockerels. In the first study, thirty birds were randomly allotted to five groups and injected, i.v., with 0.9% saline, [Gln8]-LHRH (cLHRH I, 1 μM or 10 μM) or [His5, Trp7, Tyr8]-LHRH, (cLHRH II; 1 μM or 10 μM). Blood samples were drawn prior to and through 60 min following the injection, and plasma was collected for LH determination. In the second study, anterior pituitary cells from cockerels were dispersed and preincubated for 1 hr. Approximately 1.5 × 105 cells per tube were incubated with either Medium 199 buffer (control), 8-bromo-cAMP or various doses of cLHRH I or cLHRH II at final concentrations ranging from 0.02 to 100.0 nM. At the end of a two hour incubation, supernatant was collected and the concentration of LH determined. Injection of cLHRH I or cLHRH II at 1 μM and 10 μM levels caused a significant increase in blood LH concentrations which peaked 5 min following injection. There were, however, no differences between the stimulatory effect of cLHRH I compared to cLHRH II at either dose. On the other hand, cLHRH II was found to be 4.7 times more potent than cLHRH I in stimulating LH release from dispersed pituitary cells. It is suggested that cLHRH II may have greater affinity for the gonadotroph receptor, greater uptake by the cell, and/or that it may be more resistant to in vitro degradation than cLHRH I. On the other hand, an extra pituitary site of degradation may be more effective in metabolizing cLHRH II, resulting in its equipotency with cLHRH I, in vivo.
UR - http://www.scopus.com/inward/record.url?scp=0022376748&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022376748&partnerID=8YFLogxK
U2 - 10.1016/0024-3205(85)90602-2
DO - 10.1016/0024-3205(85)90602-2
M3 - Article
C2 - 3908867
AN - SCOPUS:0022376748
SN - 0024-3205
VL - 37
SP - 2459
EP - 2465
JO - Life Sciences
JF - Life Sciences
IS - 26
ER -